Podcast appearances and mentions of Matt Wolf

Pee-Wee As Himself is an HBO Max two-part documentary exploring the life and career of Paul Reubens, known for his character Pee-wee Herman. Directed by Matt Wolf, Pee-wee as Himself is constructed around over 40 hours of candid interviews with Reubens, conducted before his passing in 2023. The film delves into his early influences in circus and avant-garde theater, his meteoric rise with Pee-wee's Playhouse and Pee-wee's Big Adventure, and the deliberate separation he maintained between his personal identity and his Pee-wee persona. The documentary also addresses the controversies that impacted Reubens' career, including his 1991 arrest and the 2002 charges related to vintage erotica, which were later dropped. In a poignant final audio message recorded shortly before his death, Reubens reflects on the pain of being misunderstood and emphasizes the importance of self-acceptance and non-conformity—a message he consistently aimed to impart to his audience. Joining Kate is two-time Emmy and Grammy award-winning comedian Kathy Griffin, one of Paul Reubens good friends. Reality Life with Kate Casey What to Watch List: https://katecasey.substack.com Patreon: http://www.patreon.com/katecasey Twitter: https://twitter.com/katecasey Instagram: http://www.instagram.com/katecaseyca Tik Tok: http://www.tiktok.com/itskatecasey Facebook Group: https://www.facebook.com/groups/113157919338245 Amazon List: https://www.amazon.com/shop/katecasey Like it to Know It: https://www.shopltk.com/explore/katecaseySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

With the recent release of "Pee Wee Herman as Himself" -- the acclaimed new two-part documentary directed and produced by Matt Wolf that is streaming now on HBO Max  -- "Naked Lunch" revisits this fascinating conversation and rare podcast appearance that happened when Phil invited his longtime friend and even longer-time hero Paul Reubens over to talk. With a new introduction by Phil. To learn more about building community through food and "Somebody Feed the People," visit the Philanthropy page at philrosenthalworld.com. 

In this episode, Matt Wolf, Valuation Leader and Healthcare Senior Analyst at Elliott Davis, unpacks how higher interest rates, global financial uncertainty, and a shift away from traditional add-on acquisitions are reshaping private equity strategy, especially in the healthcare and lower middle markets.

In this episode, Matt Wolf, Valuation Leader and Healthcare Senior Analyst at Elliott Davis, unpacks how higher interest rates, global financial uncertainty, and a shift away from traditional add-on acquisitions are reshaping private equity strategy, especially in the healthcare and lower middle markets.

CBS News president Wendy McMahon has stepped down from her post as tensions escalate over ongoing Paramount Global-Trump settlement talks. With the deal already under scrutiny from senators, what’s in store for Shari Redstone's Skydance merger? Kim Masters and Matt Belloni dive into this and more major media shake-up stories. Plus, Masters talks to director Matt Wolf about Pee-wee as Himself, which looks beyond the iconic character to the complicated man who created him. The two-part series draws from more than 40 hours of Wolf’s interviews with Paul Reubens, who spent much of his life guarding his privacy. The filmmaker also explains how those conversations revealed Reubens’ inner conflicts and why HBO pushed for more when it came to telling the late actor’s story.

The new two part documentary "Pee-wee As Himself" features some of the final interviews with comedian Paul Ruebens before his death in 2023. The documentary, directed by Matt Wolf, follows both the public and private life of Ruebens, who discusses his sexuality in detail for the first time. "Pee-wee As Himself" premieres on HBO and Max on May 23.

As Director Matt Wolf shows in his  insightful and fun 2-part HBO series “Pee-wee as Himself”, in Pee-wee, Paul Rubens found a persona that allowed him to both reveal and yet hide some core truths about who he was.     Fascinated with television and show business since he was a boy, Rubens combined elements of his childhood's pop culture with the art world of Southern California in the 70s and early 80s to craft a character that would both conquer the then punkish milieu of Melrose Avenue as well as create a nationally televised children's TV show.  To achieve this, Wolfe delineates how Rubens deliberately foreclosed both his potential love life as well as cast aside long-held friendships.  Wolfe's series demonstrates both the costs as well as the benefits of outsized talent and ambition.   You can watch “Pee-wee as Himself” on HBO and HBO Max starting Friday, May 23rd.   Follow: @mattpwolf on Instagram @topdocspod on Instagram and X    The Presenting Sponsor of "Top Docs" is Netflix.

In this episode, Matt Wolf, Valuation Leader and Healthcare Senior Analyst at Elliott Davis, joins Scott Becker to share key trends shaping private equity in healthcare, from aging portfolios and dry powder pressures to the impact of rising interest rates on deal strategy.

In this episode, Matt Wolf, Valuation Leader and Healthcare Senior Analyst at Elliott Davis, joins Scott Becker to share key trends shaping private equity in healthcare, from aging portfolios and dry powder pressures to the impact of rising interest rates on deal strategy.

In this episode, Matt Wolf, Valuation Leader and Healthcare Senior Analyst at Elliott Davis, joins Scott Becker to break down current private equity trends, shifting investor behavior, and how dealmaking is evolving in a high-rate environment.

In this episode, Matt Wolf, Valuation Leader and Healthcare Senior Analyst at Elliott Davis, joins Scott Becker to break down current private equity trends, shifting investor behavior, and how dealmaking is evolving in a high-rate environment.

In this episode, Scott Becker talks with top analyst Matt Wolf about the growing uncertainty in the private equity and M&A markets. Matt shares insights on recession risks, reduced deal activity, investor caution, and how global trade tensions are reshaping strategies in 2025.

In this episode, Scott Becker talks with top analyst Matt Wolf about the growing uncertainty in the private equity and M&A markets. Matt shares insights on recession risks, reduced deal activity, investor caution, and how global trade tensions are reshaping strategies in 2025.

Apple is falling behind in the AI race with Siri delays, AI art is gaining traction and Microsoft is developing its own models in spite of their OpenAI stake. There's a ton happening in AI and Matt Wolf from The Next Wave podcast returns to help us break it down. Plus: Air taxis are coming to the UK and law schools get even more competitive. Join our hosts Jon Weigell and Matt Wolfe as they take you through our most interesting stories of the day. Get our Side Hustle Ideas Database: https://clickhubspot.com/thds Follow us on social media: TikTok: https://www.tiktok.com/@thehustle.co Instagram: https://www.instagram.com/thehustledaily/ Thank You For Listening to The Hustle Daily Show. Don't forget to hit Subscribe or Follow us on Apple Podcasts so you never miss an episode! If you want this news delivered to your inbox, join millions of others and sign up for The Hustle Daily newsletter, here: https://thehustle.co/email/  Plus! Your engagement matters to us. If you are a fan of the show, be sure to leave us a 5-Star Review on Apple Podcasts https://podcasts.apple.com/us/podcast/the-hustle-daily-show/id1606449047 (and share your favorite episodes with your friends, clients, and colleagues).

In this episode, Matt Wolf, Healthcare Senior Analyst at RSM, breaks down the latest market trends, including declining equity values, IPO delays, and the increasing reliance on private capital.

In this episode, Matt Wolf, Healthcare Senior Analyst at RSM, breaks down the latest market trends, including declining equity values, IPO delays, and the increasing reliance on private capital.

“In terms of the big three numbers – employment, inflation, and GDP growth – our baseline forecast is optimistic,” says Matt Wolf of RSM in this economic outlook discussion with host Greg Hawver. Matt points to a 4.2% unemployment rate, two-and-a-half point inflation, and 2.5% GDP growth. But he also observes that the uncertainty of tariffs is creating “paralysis” among operators and some investors. “There's just too many variables right now to try to game out any sort of meaningful investment,” he suggests.Connect and Learn More☑️ Matt Wolf | LinkedIn☑️ RSM | LinkedIn | Facebook | Instagram | X | YouTube☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X☑️ Subscribe Apple Podcasts | Spotify | Amazon MusicThis podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, joins Scott Becker to discuss how tariffs and economic uncertainty are reshaping the deal-making landscape.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, joins Scott Becker to discuss how tariffs and economic uncertainty are reshaping the deal-making landscape.

My Locker Room youth movement producer Danny Ryan and the "intern" Andrew Leeds join me in the studio. Middle Twp HS wrestling Head coach Matt Wolf and our "HS Athletes in the Spotlight" with Fran Malaughlin.

In this episode, Matt Wolf, Senior Analyst at RSM discusses how supply chains have become nine times more complicated over the past 15 years, the impact of labor shortages, and the growing role of AI in managing business operations. Click here to learn more from RSM’s ‘The Real Economy Blog’

In this episode, Matt Wolf, Senior Analyst at RSM discusses how supply chains have become nine times more complicated over the past 15 years, the impact of labor shortages, and the growing role of AI in managing business operations. Click here to learn more from RSM’s ‘The Real Economy Blog’

Machinery Pete – Greg Peterson – gives us an update on the used machinery market and Matt Wolf, specialty crop analyst at TerrainAg, talks about population trends and the effects on demand.See omnystudio.com/listener for privacy information.

In this episode, recorded live, Matt Wolf, Healthcare Senior Analyst and National Healthcare Business Valuation Leader at RSM, joins Scott Becker to discuss the shifting exit environment in private equity.

In this episode, recorded live, Matt Wolf, Healthcare Senior Analyst and National Healthcare Business Valuation Leader at RSM, joins Scott Becker to discuss the shifting exit environment in private equity.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares key insights from recent research on the increasing complexity of business operations, the impact on private equity and middle-market companies, and strategies leaders can use to navigate today's challenging deal environment.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares key insights from recent research on the increasing complexity of business operations, the impact on private equity and middle-market companies, and strategies leaders can use to navigate today's challenging deal environment.

In this webinar-turned-podcast, industry leaders Holly Buckley, Matt Wolf, Craig Castelli, and Bart Walker discuss key trends in healthcare private equity, including state-level transaction regulations, the rise of healthcare-at-home services, and evolving exit strategies.

In this webinar-turned-podcast, industry leaders Holly Buckley, Matt Wolf, Craig Castelli, and Bart Walker discuss key trends in healthcare private equity, including state-level transaction regulations, the rise of healthcare-at-home services, and evolving exit strategies.

NYC to Break Tourism Record, Long Day’s Journey Into Film, Happy Ending for Understudies, SCHMIGADOON! @ KenCen, and Matt Wolf previews the London Stage Since 2016, “Today on Broadway” has been the first and only daily podcast recapping the top theatre headlines every Monday through Friday. Any and all feedback read more The post Today on Broadway: Tuesday, February 4, 2025 appeared first on BroadwayRadio.

Today's episode is on "Wild Combination: A Portrait of Arthur Russell", a 2008 film about the singer, instrumentalist, composer, collaborator, and all-around musical pioneer whose work has become more widely recognized well after his untimely passing. The movie is directed by Matt Wolf. Our guest today is Matty Monroe, the person behind the Indieheads subreddit and general knower and lover of all things indie music. Wild Combination is a biography of a man who was hard to know. He didn't leave a lot of surviving interviews, spoken audio, or writing. But he left behind a vast trove of music which is still being discovered and released. The film reflects on his beautiful relationship with his longtime partner Tom Lee, his parents, Chuck and Emily Russell, and the many musicians and artists who had the opportunity to work with Arthur. Plus there are some weird vibes from Rock Docs regular Allen Ginsberg. Arthur Russell's music is singular and transporting, and the movie is a fine tribute to the man and his work. Rock Docs is a Treble Media Podcast hosted by David Lizerbram & Andrew Keatts Twitter: @RockDocsPod   Instagram: @RockDocsPod   Cover Art by N.C. Winters - check him out on Instagram at @NCWintersArt  

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, provides a nuanced analysis of the DeepSeek AI model and the broader cost reduction trends in AI development.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, provides a nuanced analysis of the DeepSeek AI model and the broader cost reduction trends in AI development.

In this episode, Scott Becker is joined by Matt Wolf, Healthcare Senior Analyst and National Healthcare Business Valuation Leader at RSM. Matt discusses the evolving trends in healthcare private equity, the impact of interest rates on deal flow, and the growing focus on healthcare technology over reimbursement-based businesses.

In this episode, Scott Becker is joined by Matt Wolf, Healthcare Senior Analyst and National Healthcare Business Valuation Leader at RSM. Matt discusses the evolving trends in healthcare private equity, the impact of interest rates on deal flow, and the growing focus on healthcare technology over reimbursement-based businesses.

Nancy Durrant and Matt Wolf join Robert Bound in the studio to discuss the best theatre shows coming to the stage in 2025, including a new production of a West End classic, a play about the experiences of the Windrush generation and a critically acclaimed performance by an Olivier award-winning actress. See omnystudio.com/listener for privacy information.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his insights on the shifting interest rate environment and its implications for capital markets in 2025.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his insights on the shifting interest rate environment and its implications for capital markets in 2025.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his outlook for the 2025 deal market, highlighting key trends, challenges, and opportunities in the middle market.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his outlook for the 2025 deal market, highlighting key trends, challenges, and opportunities in the middle market.

In this episode, Matt Wolf, of RSM, discusses the ongoing shift of capital from public equity markets to private equity and credit.

In this episode, Matt Wolf, of RSM, discusses the ongoing shift of capital from public equity markets to private equity and credit.

In this episode, Scott Becker is joined by Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM. Matt shares insights on the potential for a robust IPO market in 2025, the shift toward mature, profitable companies going public, and how private equity funds are adapting with creative liquidity solutions.

In this episode, Scott Becker is joined by Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, to discuss RSM's 2025 economic forecast. They delve into projections for GDP growth, employment trends, the private equity landscape, and the potential impact of regulatory changes under the incoming administration. Matt also […]

In this episode, Scott Becker speaks with Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM. Matt shares insights into the current deal-making landscape, discussing how inflation, policy uncertainty, and market dynamics are shaping opportunities in private equity.

In this episode, Scott Becker interviews Matt Wolf, Senior Analyst and National Healthcare Business Valuation Leader at RSM, to discuss the state of private equity deal activity, the impact of regulatory changes, and insights into the current fundraising environment. Matt shares his perspective on trends in operational efficiency and the evolving preferences of institutional investors.

In this episode, Matt Wolf, Healthcare Senior Analyst and National Health Care Business Valuation Leader at RSM, joins Scott Becker to discuss the latest trends in private equity. Matt shares insights on the recent surge in deal volume, the impact of interest rates on diligence, and how sponsors are adapting their strategies in today's changing […]

In this episode, Matt Wolf, Healthcare Senior Analyst and Business Valuation Leader at RSM, joins Scott Becker to explore how changing interest rates and macroeconomic conditions are influencing strategic investors in the private equity space. They discuss the impact on acquisitions, divestitures, and deal-making strategies for healthcare and beyond.

In this episode, Matt Wolf, Health Care Senior Analyst and National Business Valuation Leader at RSM, discusses the impact of productivity trends on economic growth and the potential of generative AI to revolutionize healthcare. He explores how these technologies could free up clinical time and drive enterprise value in the coming years.

In this episode, Scott Becker speaks with Matt Wolf, Senior Analyst and National Health Care Business Valuation Leader at RSM, about the impact of recent interest rate cuts on deal activity. They discuss the rise in deal interest, the complexity of purchase structures, and the critical role of management teams in future transactions.